Teva to Present New Data from CONNECT2 Study on its Digihale

24.02.2023 - Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that new data on its Digihaler System will be presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) ... Seite 1

Related Keywords

Tanisha Hill , Digital Health Platform , Drug Administration , Digital Health Medical Lead At Teva , Real World Digihaler System , Digihaler System , Senior Medical Director , Digital Health Medical Lead , Teva Pharmaceutical Industries ,